The Impact of the COVID-19 Pandemic on Menstrual Cycle in Saudi Females in Jeddah City DOI Open Access
Nedaa Bahkali,

Reham Ahmad Alsharif,

Dana Sawan

et al.

International Journal of Women s Health and Reproduction Sciences, Journal Year: 2023, Volume and Issue: 12(4), P. 160 - 166

Published: Dec. 8, 2023

Objectives: This study aimed to determine the impact of COVID-19 on menstrual cycle Saudi females in Jeddah City. Materials and Methods: In this cross-sectional study, we conducted a total 421 online surveys phone call interviews with participants between 19 45 years age, living City, Arabia, who were not pregnant, had no gynecological problems or abnormalities. Interviews January April 2022, data analyzed using SPSS version 23. Results: Most responders single normal body mass index (BMI). During pandemic, majority (75.8%) did have heavy, unpleasant periods (54.6%), missed (54.6%, 78.1%, respectively). The reported changes observed terms premenstrual symptoms (PMS) (61.5%), libido/sex drive remained unchanged for most (88.1%). Of those heavy (n=125), 18.4% (n=23) changes. 239 experience pain before COVID-19, nine (3.8%) experiencing it during pandemic. Conclusions: There significant period women bleeding, painful periods, small differences psychological challenges

Language: Английский

Association between COVID-19 vaccination and menstruation: a state of the science review DOI
Laura A. Payne, Lauren A. Wise, Amelia K. Wesselink

et al.

BMJ Sexual & Reproductive Health, Journal Year: 2024, Volume and Issue: 50(3), P. 212 - 225

Published: June 10, 2024

Menstrual health is a key patient-reported outcome beyond its importance as general indicator of and fertility. However, menstrual function was not measured in the clinical trials COVID-19 vaccines. The purpose this review to synthesise existing literature on relationship between vaccination outcomes.

Language: Английский

Citations

9
Menstrual disorders following COVID-19 vaccination: a review using a systematic search DOI Creative Commons

Veerle R. Smaardijk,

Rana Jajou, A. Kant

et al.

Frontiers in Drug Safety and Regulation, Journal Year: 2024, Volume and Issue: 4

Published: Jan. 31, 2024

Introduction: Menstrual disorders are commonly reported after COVID-19 vaccination and heavy menstrual bleeding was added to the product information of vaccines Moderna Pfizer. The aim this review, using a systematic search, is provide an overview available literature on risk vaccination. Methods: review conducted according Preferred Reporting Items for Systematic reviews Meta-Analysis (PRISMA) guidelines. A PubMed search performed 15 August 2023, including solely quantitative studies in English Dutch. Results: total 61 were included, which 40 cross-sectional studies, 18 cohort three self-controlled case series. Outcomes included wide variety disorders, changes cycle length ( n = 54), amount 44), menses 30), experience (pre)menstrual pain 21), breakthrough 18). All found higher percentage at least one disorder first different types doses. Discussion: In conclusion, evidence suggests that may cause women reproductive age. However, there need more longitudinal because important limitations study designs many studies. Although short-lived predominantly mild, it healthcare professionals be informed about these potential adverse reactions assess events clinical trials vaccines.

Language: Английский

Citations

7
Adverse Menstrual Events Reported After and Before (or Without) COVID‐19 Vaccination: A Systematic Review and Meta‐Analysis of Comparative Observational Studies DOI Creative Commons
Frank Peinemann, Doris Oberle,

Ursula Drechsel‐Bäuerle

et al.

Pharmacoepidemiology and Drug Safety, Journal Year: 2024, Volume and Issue: 33(8)

Published: Aug. 1, 2024

ABSTRACT Background Reports of adverse menstrual events emerged during the COVID‐19 vaccination campaign in multiple countries. This raised question whether these reports were caused by vaccines. The aim this systematic review was to evaluate comparative studies on topic (registered at PROSPERO [CRD42022324973]). Methods We included observational such as cohort and surveys comparing response self‐reported questionnaires between post‐ versus pre‐vaccination data. PubMed Cochrane Library searches conducted 1 September 2023. primary outcome incidence any prespecified event, measure risk ratio. meta‐analysis using Mantel–Haenszel method random effects model. summarized results factors well key findings included. Results retrieved 161 references from electronic databases additional sources lists. Of those, we considered 21 studies. event reported 12 resulted a pooled estimate (risk ratio 1.13; 95% CI, 0.96–1.31) that did not favor group. analysis constrained considerable clinical statistical heterogeneity. Risk for changes history infection, concern about vaccines, smoking, previous cycle irregularities, depression, stress, other issues. Conclusions group heterogeneity prevalent among Most suggested temporary, minor, nonserious.

Language: Английский

Citations

2
Covid-19 vaccination and menstrual bleeding disturbances among women of fertile age: a Norwegian registry study DOI Creative Commons
Maria C. Magnus, Ida Henriette Caspersen, Knut‐Arne Wensaas

et al.

European Journal of Epidemiology, Journal Year: 2024, Volume and Issue: 39(10), P. 1127 - 1138

Published: Oct. 1, 2024

Abstract This study evaluated the relationship between Covid-19 vaccination and menstrual bleeding disturbances using a large national registry linkage including 666,467 women 20 40 years of age residing in Norway on January 1st, 2019. Information vaccination—BNT162b2 mRNA-1273 — was obtained from Norwegian registry. Diagnoses (absent/scanty, excessive, irregular/frequent menstruation, intermenstrual bleeding) general practitioner database. We examined new-onset Cox regression comparing vaccinated to unvaccinated women, where contributed follow-up time as until day vaccination. In addition, we conducted self-controlled case-series analysis, sensitivity analysis excluding all those who remained throughout pandemic, evaluate role unmeasured confounding. observed an increased risk several after against Covid-19, ranging adjusted HR (aHR) 1.18 (95% CI: 1.04, 1.33) for 1.29 1.23, 1.36) periods. However, estimates were fully attenuated when at end (aHRs 0.97 1.08). No differences identified according vaccine dose or type. Our case series confirmed no first vaccination, though there slightly 61 days with 2. conclusion, modestly appeared reflect confounding by never received vaccinations, associations did not remain compared before among ever women.

Language: Английский

Citations

1
The Impact of the COVID-19 Pandemic on Menstrual Cycle in Saudi Females in Jeddah City DOI Open Access
Nedaa Bahkali,

Reham Ahmad Alsharif,

Dana Sawan

et al.

International Journal of Women s Health and Reproduction Sciences, Journal Year: 2023, Volume and Issue: 12(4), P. 160 - 166

Published: Dec. 8, 2023

Objectives: This study aimed to determine the impact of COVID-19 on menstrual cycle Saudi females in Jeddah City. Materials and Methods: In this cross-sectional study, we conducted a total 421 online surveys phone call interviews with participants between 19 45 years age, living City, Arabia, who were not pregnant, had no gynecological problems or abnormalities. Interviews January April 2022, data analyzed using SPSS version 23. Results: Most responders single normal body mass index (BMI). During pandemic, majority (75.8%) did have heavy, unpleasant periods (54.6%), missed (54.6%, 78.1%, respectively). The reported changes observed terms premenstrual symptoms (PMS) (61.5%), libido/sex drive remained unchanged for most (88.1%). Of those heavy (n=125), 18.4% (n=23) changes. 239 experience pain before COVID-19, nine (3.8%) experiencing it during pandemic. Conclusions: There significant period women bleeding, painful periods, small differences psychological challenges

Language: Английский

Citations

0